Premium
COVID ‐19 convalescent plasma; time for “goal directed therapy”?
Author(s) -
Knudson Charles Michael,
Jackson J. Brooks
Publication year - 2021
Publication title -
transfusion
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.045
H-Index - 132
eISSN - 1537-2995
pISSN - 0041-1132
DOI - 10.1111/trf.16381
Subject(s) - medicine , cryoprecipitate , transfusion medicine , transfusion therapy , convalescent plasma , intensive care medicine , covid-19 , hematocrit , randomized controlled trial , blood transfusion , clinical trial , fibrinogen , disease , infectious disease (medical specialty)